The impact of certification of general thoracic surgeons on lung cancer mortality: a survey by The Japanese Association for Thoracic Surgery

Lung cancer is still leading in the structure of cancer incidence and mortality worldwide. Delay in appropriate treatment increases the probability of death from this disease. Purpose: to study foreign scientific publications of recent years on the mortality from lung cancer due to delayed treatment. Results: The analysis of global literature for 2010-2020 shows that any delay in lung cancer treatment after establishing the diagnosis reduces the survival rates. Recent studies provide a qualitative assessment of the effect of delay in treatment on cancer mortality for prioritization and modeling. The indications for surgery, systemic treatment, and radiation therapy in seven types of cancer, including lung cancer, evidence a significant association between delay in treatment and increased mortality. The researchers believe that early diagnostics increase the treatment efficacy. Conclusion: Analyzing the barriers to timely treatment for lung cancer can help clarify and assess the impact of delayed treatment on survival. Policies designed to minimize delays in treatment can improve survival outcomes.

Download Full-text

Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study

Respiratory Medicine ◽

10.1016/j.rmed.2013.01.013 ◽

2013 ◽

Vol 107 (5) ◽

pp. 702-707 ◽

Cited By ~ 36

Author(s):

Juan P. de-Torres ◽

Ciro Casanova ◽

Jose M. Marín ◽

Jorge Zagaceta ◽

Ana B. Alcaide ◽

...

Keyword(s):

Lung Cancer ◽

Pilot Study ◽

Cancer Mortality ◽

Low Dose ◽

Lung Cancer Mortality ◽

Low Dose Ct ◽

Copd Patients ◽

The Impact

Download Full-text

Abstract CN03-03: The impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000

10.1158/1940-6215.prev-13-cn03-03 ◽

2013 ◽

Cited By ~ 1

Author(s):

Suresh Moolgavkar

Keyword(s):

United States ◽

Lung Cancer ◽

Tobacco Smoking ◽

Cancer Mortality ◽

Lung Cancer Mortality ◽

The United States ◽

The Impact

Download Full-text

Assessing Progress in Reducing the Burden of Cancer Mortality, 1985-2005

Journal of Clinical Oncology ◽

10.1200/jco.2013.50.8952 ◽

2014 ◽

Vol 32 (5) ◽

pp. 444-448 ◽

Cited By ~ 12

Author(s):

Samir Soneji ◽

Hiram Beltrán-Sánchez ◽

Harold C. Sox

Keyword(s):

Lung Cancer ◽

Cancer Incidence ◽

Cancer Mortality ◽

Lung Cancer Mortality ◽

Mortality Rates ◽

Years Of Life Lost ◽

Average Person ◽

Two Factors ◽

The Impact ◽

Cvd Mortality

Purpose Measuring the effect of cancer interventions must take into account rising cancer incidence now that people live longer because of declines in mortality from cardiovascular disease (CVD). Cancer mortality rates in the population do not accomplish this objective. We sought a measure that would reveal the effects of changing mortality rates from other diseases. Methods We obtained annual breast, colorectal, lung, and prostate cancer mortality rates from the Surveillance, Epidemiology, and End Results registries; we obtained noncancer mortality rates from national death certificates, 1975 to 2005. We used life-table methods to calculate the burden of cancer mortality as the average person-years of life lost (PYLL) as a result of cancer (cancer-specific PYLL) and quantify individual—and perhaps offsetting—contributions of the two factors that affect cancer-specific PYLL: mortality rates as a result of cancer and other-cause mortality. Results Falling cancer mortality rates reduced the burden of mortality from leading cancers, but increasing cancer incidence as a result of decreasing other-cause mortality rates partially offset this progress. Between 1985 and 1989 and between 2000 and 2004, the burden of lung cancer in males declined by 0.1 year of life lost. This decline reflects the sum of two effects: decreasing lung cancer mortality rates that reduced the average burden of lung cancer mortality by 0.33 years of life lost and declining other-cause mortality rates that raised it by 0.23 years. Other common cancers showed similar patterns. Conclusion By using a measure that accounts for increased cancer incidence as a result of improvements in CVD mortality, we find that prior assessments have underestimated the impact of cancer interventions.

Download Full-text

Lung cancer mortality due to delayed treatment: Literature review

Oncologia i radiologia Kazakhstana ◽

10.52532/2521-6414-2021-2-60-36-38 ◽

2021 ◽

Vol 60 (2) ◽

pp. 36-38

Author(s):

B. А. Abdurakhmanov ◽

Z. К. Avizovа

Keyword(s):

Lung Cancer ◽

Cancer Mortality ◽

Survival Rates ◽

Lung Cancer Mortality ◽

Qualitative Assessment ◽

Scientific Publications ◽

Delayed Treatment ◽

Incidence And Mortality ◽

The Impact ◽

Delay In Treatment

Relevance: Lung cancer is still leading in the structure of cancer incidence and mortality worldwide. Delay in appropriate treatment increases the probability of death from this disease. Purpose: to study foreign scientific publications of recent years on the mortality from lung cancer due to delayed treatment. Results: The analysis of global literature for 2010- 2020 shows that any delay in lung cancer treatment after establishing the diagnoses reduces the survival rates. Recent studies provide a qualitative assessment of the effect of delay in treatment on cancer mortality for prioritization and modeling. The indications for surgery, systemic treatment, and radiation therapy in seven types of cancer, including lung cancer, evidence a significant association between delay in treatment and increased mortality. The researchers believe that early diagnostics increase the treatment efficacy. Conclusion: Analyzing the barriers to timely treatment for lung cancer can help clarify and assess the impact of delayed treatment on survival. Policies designed to minimize delays in treatment can improve survival outcomes.

Download Full-text

Socioeconomic disparities in cancer incidence and mortality in England and the impact of age-at-diagnosis on cancer mortality

PLoS ONE ◽

10.1371/journal.pone.0253854 ◽

2021 ◽

Vol 16 (7) ◽

pp. e0253854

Author(s):

Ayşe Arık ◽

Erengul Dodd ◽

Andrew Cairns ◽

George Streftaris

Keyword(s):

Lung Cancer ◽

Cancer Diagnosis ◽

Cancer Incidence ◽

Cancer Mortality ◽

Lung Cancer Mortality ◽

Socioeconomic Disparities ◽

Morbidity And Mortality ◽

Cancer Morbidity ◽

The Impact ◽

Female Lung Cancer

Background We identify socioeconomic disparities by region in cancer morbidity and mortality in England for all-cancer and type-specific cancers, and use incidence data to quantify the impact of cancer diagnosis delays on cancer deaths between 2001–2016. Methods and findings We obtain population cancer morbidity and mortality rates at various age, year, gender, deprivation, and region levels based on a Bayesian approach. A significant increase in type-specific cancer deaths, which can also vary among regions, is shown as a result of delay in cancer diagnoses. Our analysis suggests increase of 7.75% (7.42% to 8.25%) in female lung cancer mortality in London, as an impact of 12-month delay in cancer diagnosis, and a 3.39% (3.29% to 3.48%) increase in male lung cancer mortality across all regions. The same delay can cause a 23.56% (23.09% to 24.30%) increase in male bowel cancer mortality. Furthermore, for all-cancer mortality, the highest increase in deprivation gap happened in the East Midlands, from 199 (186 to 212) in 2001, to 239 (224 to 252) in 2016 for males, and from 114 (107 to 121) to 163 (155 to 171) for females. Also, for female lung cancer, the deprivation gap has widened with the highest change in the North West, e.g. for incidence from 180 (172 to 188) to 272 (261 to 282), whereas it has narrowed for prostate cancer incidence with the biggest reduction in the South West from 165 (139 to 190) in 2001 to 95 (72 to 117) in 2016. Conclusions The analysis reveals considerable disparities in all-cancer and some type-specific cancers with respect to socioeconomic status. Furthermore, a significant increase in cancer deaths is shown as a result of delays in cancer diagnoses which can be linked to concerns about the effect of delay in cancer screening and diagnosis during the COVID-19 pandemic. Public health interventions at regional and deprivation level can contribute to prevention of cancer deaths.

Download Full-text